Structure Therapeutics (GPCR) Total Liabilities (2022 - 2026)
Quarterly Total Liabilities rose 45.62% to $61.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $61.0 million through Mar 2026, up 45.62% year-over-year, with the annual reading at $67.5 million for FY2025, 75.49% up from the prior year.
Structure Therapeutics' Total Liabilities history spans 5 years, with the latest figure at $61.0 million for Q1 2026.
- Total Liabilities came in at $61.0 million for Q1 2026, down from $67.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $103.9 million in Q3 2022 to a low of $11.0 million in Q1 2023.
- The 5-year median for Total Liabilities is $38.5 million (2024), against an average of $45.3 million.
- Year-over-year, Total Liabilities crashed 85.75% in 2023 and then surged 149.11% in 2024.
- Structure Therapeutics' Total Liabilities stood at $13.0 million in 2022, then surged by 123.3% to $29.1 million in 2023, then soared by 32.48% to $38.5 million in 2024, then skyrocketed by 75.49% to $67.5 million in 2025, then decreased by 9.64% to $61.0 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Total Liabilities are $61.0 million (Q1 2026), $67.5 million (Q4 2025), and $62.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 9.45 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 10.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 61.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.03 Mn |
| Dec 31, 2025 | 67.54 Mn |
| Sep 30, 2025 | 62.14 Mn |
| Jun 30, 2025 | 44.36 Mn |
| Mar 31, 2025 | 41.91 Mn |
| Dec 31, 2024 | 38.49 Mn |
| Sep 30, 2024 | 36.42 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 27.41 Mn |
| Dec 31, 2023 | 29.05 Mn |
| Sep 30, 2023 | 23.41 Mn |
| Jun 30, 2023 | 15.01 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 13.01 Mn |
| Sep 30, 2022 | 103.91 Mn |
| Jun 30, 2022 | 92.10 Mn |
| Mar 31, 2022 | 77.23 Mn |